[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Insulin Syringes-Global Market Status and Trend Report 2013-2023

February 2018 | 146 pages | ID: IF83F9CE3EBEN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Insulin Syringes-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Insulin Syringes industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Insulin Syringes 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Insulin Syringes worldwide, with company and product introduction, position in the Insulin Syringes market
Market status and development trend of Insulin Syringes by types and applications
Cost and profit status of Insulin Syringes, and marketing status
Market growth drivers and challenges

The report segments the global Insulin Syringes market as:

Global Insulin Syringes Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Insulin Syringes Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Insulin Pens
Insulin Pumps
Pen Needles
Insulin Syringes

Global Insulin Syringes Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Patients/Homecare
Hospitals & Clinics

Global Insulin Syringes Market: Manufacturers Segment Analysis (Company and Product introduction, Insulin Syringes Sales Volume, Revenue, Price and Gross Margin):

Animas Corporation (Johnson and Johnson)
Becton, Dickinson and Company
Biocon Limited
ELI Lilly and Company
Insulet Corporation
Medtronic PLC
Novo Nordisk A/S
Sanofi
Tandem Diabetes Care, Inc.
Ypsomed Holding AG

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INSULIN SYRINGES

1.1 Definition of Insulin Syringes in This Report
1.2 Commercial Types of Insulin Syringes
  1.2.1 Insulin Pens
  1.2.2 Insulin Pumps
  1.2.3 Pen Needles
  1.2.4 Insulin Syringes
1.3 Downstream Application of Insulin Syringes
  1.3.1 Patients/Homecare
  1.3.2 Hospitals & Clinics
1.4 Development History of Insulin Syringes
1.5 Market Status and Trend of Insulin Syringes 2013-2023
  1.5.1 Global Insulin Syringes Market Status and Trend 2013-2023
  1.5.2 Regional Insulin Syringes Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Insulin Syringes 2013-2017
2.2 Production Market of Insulin Syringes by Regions
  2.2.1 Production Volume of Insulin Syringes by Regions
  2.2.2 Production Value of Insulin Syringes by Regions
2.3 Demand Market of Insulin Syringes by Regions
2.4 Production and Demand Status of Insulin Syringes by Regions
  2.4.1 Production and Demand Status of Insulin Syringes by Regions 2013-2017
  2.4.2 Import and Export Status of Insulin Syringes by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Insulin Syringes by Types
3.2 Production Value of Insulin Syringes by Types
3.3 Market Forecast of Insulin Syringes by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Insulin Syringes by Downstream Industry
4.2 Market Forecast of Insulin Syringes by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF INSULIN SYRINGES

5.1 Global Economy Situation and Trend Overview
5.2 Insulin Syringes Downstream Industry Situation and Trend Overview

CHAPTER 6 INSULIN SYRINGES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Insulin Syringes by Major Manufacturers
6.2 Production Value of Insulin Syringes by Major Manufacturers
6.3 Basic Information of Insulin Syringes by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Insulin Syringes Major Manufacturer
  6.3.2 Employees and Revenue Level of Insulin Syringes Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 INSULIN SYRINGES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Animas Corporation (Johnson and Johnson)
  7.1.1 Company profile
  7.1.2 Representative Insulin Syringes Product
  7.1.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Animas Corporation (Johnson and Johnson)
7.2 Becton, Dickinson and Company
  7.2.1 Company profile
  7.2.2 Representative Insulin Syringes Product
  7.2.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company
7.3 Biocon Limited
  7.3.1 Company profile
  7.3.2 Representative Insulin Syringes Product
  7.3.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Biocon Limited
7.4 ELI Lilly and Company
  7.4.1 Company profile
  7.4.2 Representative Insulin Syringes Product
  7.4.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of ELI Lilly and Company
7.5 Insulet Corporation
  7.5.1 Company profile
  7.5.2 Representative Insulin Syringes Product
  7.5.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Insulet Corporation
7.6 Medtronic PLC
  7.6.1 Company profile
  7.6.2 Representative Insulin Syringes Product
  7.6.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Medtronic PLC
7.7 Novo Nordisk A/S
  7.7.1 Company profile
  7.7.2 Representative Insulin Syringes Product
  7.7.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.8 Sanofi
  7.8.1 Company profile
  7.8.2 Representative Insulin Syringes Product
  7.8.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Sanofi
7.9 Tandem Diabetes Care, Inc.
  7.9.1 Company profile
  7.9.2 Representative Insulin Syringes Product
  7.9.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Tandem Diabetes Care, Inc.
7.10 Ypsomed Holding AG
  7.10.1 Company profile
  7.10.2 Representative Insulin Syringes Product
  7.10.3 Insulin Syringes Sales, Revenue, Price and Gross Margin of Ypsomed Holding AG

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN SYRINGES

8.1 Industry Chain of Insulin Syringes
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF INSULIN SYRINGES

9.1 Cost Structure Analysis of Insulin Syringes
9.2 Raw Materials Cost Analysis of Insulin Syringes
9.3 Labor Cost Analysis of Insulin Syringes
9.4 Manufacturing Expenses Analysis of Insulin Syringes

CHAPTER 10 MARKETING STATUS ANALYSIS OF INSULIN SYRINGES

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications